Divesting seven consumer health brands doesn’t rate a mention by GlaxoSmithKline plc while the US firm gaining the lines touts the deal as extending its footprint to an additional 32 countries.
The deal Foundation Consumer Brands LCC announced on 16 July marks GSK’s latest sale of OTC and nutritional product brands that aren’t strong enough revenue drivers to remain part of its consumer
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?